We have an exciting opportunity for a Postdoctoral Scientist with an interest in applying state-of-the-art mass spectrometry technology to understand effects of antigen processing on immunological landscapes in cancer. We are seeking an exceptional, enthusiastic and motivated scientist with a passion for novel approaches and technological advances.
About the position:
- The position is based at the Antigen Discovery Group at the Centre for Cellular and Molecular Physiology, The Jenner Institute, University of Oxford, and the candidate will be reporting to Dr. Nicola Ternette.
- The research program will be carried out together with Grey Wolf Therapeutics, enabling the candidate to work in a research environment formed by academia and industry that aims to evaluate early stage anti-tumour therapeutics through to clinical application.
- You will join a research programme that aims to understand the effects of therapeutic intervention with the antigen processing machinery on the presentation of (neo) antigens in cancer, and will be focussed on the analysis of immunopeptidomes of cultured cells and primary tissues by liquid chromatography tandem mass spectrometry (LC-MS/MS).
- You will have a PhD (or close to completion) in the field of Biochemistry or a related discipline, with working knowledge of proteomics methods and the analysis of MS data.
- You are also expected to have the ability to communicate results clearly and effectively and to discuss scientific ideas both within the work environment and the wider collaborative community.
How to Apply:
- Applications for this vacancy are to be made online and you will be required to upload a supporting statement and CV as part of your online application.
- This full-time position is fixed-term until 30 June 2021 and is funded by Grey Wolf Therapeutics.
|Organization||University of Oxford|
|Type of position||Postdoctoral|
|Subject areas||Biochemistry Cellular and Molecular Physiology|